ITC Pharma GmbH

ITC Pharma GmbH is a German company specialized in marketing and distribution of pharmaceutical and biological products within the Middle East and Africa region. With a regional office in Dubai, the company engages with local partners for business development and alliances. ITC Pharma holds a marketing authorization for certain products in different countries and has its own brands, including the Sevoflurane ITC Pharma inhaler - an FDA approved product with high-quality standards. The company's anesthesia line is expanding to meet healthcare partners' needs and serve stakeholders within the healthcare sector. ITC Pharma's strategy revolves around four key pillars. Firstly, it aims to provide high-quality, cost-effective products to healthcare partners, placing patients at the center of priorities. Secondly, the company seeks to diversify its product portfolio to address potential medical needs and cater to a wider range of specialized stakeholders. Additionally, ITC Pharma is focused on offering world-class services in the markets it operates in and acting as a real partner in healthcare for local authorities and service providers. Lastly, the company aims to establish long-term partnerships and alliances with esteemed regional pharmaceutical distributors to achieve a win-win situation and maximize patients' outcomes. Founded in 2007, ITC Pharma operates within the pharmaceutical, retail, and marketing industries, with its headquarters in Germany. The company's exciting vision involves attaining a leading position with healthcare partners by offering life-changing, cost-effective quality products that treat debilitating diseases, ultimately aiming to enhance the quality of life for millions of people in the Middle East and Africa. Currently, there is no publicly disclosed information regarding the company's last investment or its investors.